Quarterly report [Sections 13 or 15(d)]

Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity

v3.26.3
Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Options
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Options
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     79,419,028        
Beginning balance at Dec. 31, 2024 $ 221,938   $ 7 $ 407,076   $ 1,753 $ (186,898)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)     1,977,499        
Issuance of common stock upon exercise of stock options 139     139      
Issuance of common stock upon settlement of restricted stock units (in shares)     3,468,117        
Issuance of common stock upon settlement of restricted stock units 0            
Stock-based compensation - restricted stock 11,391     11,391      
Shares withheld related to net share settlement (in shares)     (2,248,336)        
Shares withheld related to net share settlement (7,309)     (7,309)      
Issuance of common stock in acquisition (in shares)     3,434,609        
Issuance of common stock in acquisition 8,414     8,414      
Other comprehensive loss (1,753)         (1,753)  
Net income (loss) 50,180           50,180
Ending balance (in shares) at Sep. 30, 2025     86,050,917        
Ending balance at Sep. 30, 2025 283,000   $ 7 419,711   0 (136,718)
Beginning balance (in shares) at Jun. 30, 2025     81,695,605        
Beginning balance at Jun. 30, 2025 223,100   $ 7 411,259   5,968 (194,134)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)     365,652        
Issuance of common stock upon exercise of stock options 65     65      
Issuance of common stock upon settlement of restricted stock units (in shares)     1,017,440        
Issuance of common stock upon settlement of restricted stock units 0            
Stock-based compensation - restricted stock 1,825     1,825      
Shares withheld related to net share settlement (in shares)     (462,389)        
Shares withheld related to net share settlement (1,852)     (1,852)      
Issuance of common stock in acquisition (in shares)     3,434,609        
Issuance of common stock in acquisition 8,414     8,414      
Other comprehensive loss (5,968)         (5,968)  
Net income (loss) 57,416           57,416
Ending balance (in shares) at Sep. 30, 2025     86,050,917        
Ending balance at Sep. 30, 2025 283,000   $ 7 419,711   0 (136,718)
Beginning balance (in shares) at Dec. 31, 2025     86,702,183        
Beginning balance at Dec. 31, 2025 $ 279,072   $ 7 424,616   0 (145,551)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares) 325,960   325,960        
Issuance of common stock upon exercise of stock options $ 59     59      
Issuance of common stock upon settlement of restricted stock units (in shares)     3,967,053        
Issuance of common stock upon settlement of restricted stock units 0            
Stock-based compensation - restricted stock 13,790 $ 3,366   13,790 $ 3,366    
Shares withheld related to net share settlement (in shares)     (1,744,065)        
Shares withheld related to net share settlement (8,874)     (8,874)      
Issuance of common stock in acquisition (in shares)     742,060        
Issuance of common stock in acquisition 4,267     4,267      
Retirement of common stock (in shares)     (675,334)        
Retirement of common stock 0            
Non-cash capital contribution 672     672      
Other comprehensive loss 0            
Net income (loss) (15,977)           (15,977)
Ending balance (in shares) at Sep. 30, 2026     89,317,857        
Ending balance at Sep. 30, 2026 276,375   $ 7 437,896   0 (161,528)
Beginning balance (in shares) at Jun. 30, 2026     88,466,806        
Beginning balance at Jun. 30, 2026 279,318   $ 7 433,224   0 (153,913)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares)     14,000        
Issuance of common stock upon exercise of stock options 4     4      
Issuance of common stock upon settlement of restricted stock units (in shares)     1,626,589        
Issuance of common stock upon settlement of restricted stock units 0            
Stock-based compensation - restricted stock 5,049 $ 3,366   5,049 $ 3,366    
Shares withheld related to net share settlement (in shares)     (789,538)        
Shares withheld related to net share settlement (4,086)     (4,086)      
Non-cash capital contribution 339     339      
Other comprehensive loss 0            
Net income (loss) (7,615)           (7,615)
Ending balance (in shares) at Sep. 30, 2026     89,317,857        
Ending balance at Sep. 30, 2026 $ 276,375   $ 7 $ 437,896   $ 0 $ (161,528)